Fifteen patients with metastatic DTIC-resistant malignant melanoma were treated with vinblastine, bleomycin and methotrexate combination chemotherapy. Three patients showed an objective response (one complete response). The therapy was well tolerated and easy to administer. This combination appears to produce in DTIC-resistant patients a response rate similar to that obtained with DTIC.
Get full access to this article
View all access options for this article.
References
1.
AhmAnnD.L.: Nitrosoureas in the management of disseminated malignant melanoma.Cancer Treat. Rep.,60: 747–751, 1976.
2.
AhmannD.L., HahnR.G., BiselH.F., EaganR.T., EdmonsonJ.H.: Comparative study of methyl-CCNU (NSC-95441) with cyclophosphamide (NSC-26271) and 5-(3,3-dimethyl-l-triazeno)imidazole-4-carboxamide (NSC-45388) with vincristine (NSC-67574) in patients with disseminated malignant melanoma.Cancer Treat. Rep.,59: 451–453, 1975.
3.
BerettaG.: Recenti progressi nella terapia medica dei sarcomi dei tessuti molli e del melanoma. 2° Corso di Aggiornamento AIOM in Oncologia Medica, pp. 317–334, Milano, 10-12 Dicembre 1975.
4.
BerettaG., BonadonnaG., CascinelliN., MorabitoA., VeronesiU.: Comparative evaluation of three combinations regimens for advanced malignant melanoma: Results of an International Cooperative Study.Cancer Treat. Rep.,60: 33–40, 1976.
CaterS.K., FriedmanM.A.: 5-(3,3 dimethyl-l-triazeno)-imidazole-4-carboxamide (DTIC, DIC, NSC-45388). A new antitumor agent with activity against malignant melanoma.Eur. J. Cancer,8: 85–92, 1972.
7.
ComisR.L.: DTIC (NSC-54388) in malignant melanoma: A perspective.Cancer Treat. Rep.,60: 165–176, 1976.
8.
ComisR.L., CarterS.M.: Integration of combined modality therapy of solid tumors.Malignant melanoma. Cancer Treat. Rev.,1: 285–304, 1974.
De WaschG., BernheimM.J., MichelJ., LejeuneF., KenisY.: Combination chemotherapy with three marginally effective agents, CCNU, vincristine and bleomycin in the treatment of stage III melanoma.Cancer Treat. Rep.,60: 1273–1276, 1976.
11.
McKelveyE.M., LuceJ.K., TalleyR.W., HershE.M., HewlettJ.S., MoonT.E.: Combination chemotherapy with bis-chloroethyl-nitrosourea (BCNU), vincristine and dimethyltriazeno-imidazole-carboxamide (DTIC) in disseminated malignant melanoma.Cancer,39: 1–4, 1977.
12.
McKelveyE.M., LuceJ.K., VaitkeviciusV.K., TalleyR.W., BodeyG.P., LaneM., MoonT.E.: Bis chloroethyl nitrosoureas, vincristine, dimethyltriazeno imidazole carboxamide and chlorpromazine combination chemotherapy in disseminated malignant melanoma.Cancer,39: 5–10, 1977.
13.
WassermanT.H., ComisR.L., GoldsmithM., HandelsmanH., PentaJ.S., SlavikM., SaperW.T., CarterS.K.: Tabular analysis of the clinical chemotherapy of solid tumors.Cancer Chemother. Rep.,6: 399–413, 1975.
